Lowering of mean pulmonary arterial pressure is a prognostic marker in pulmonary hypertension patients treated with subcutaneous treprostinil

Authors: R Sadushi-Kolici, I Shafran, N Skoro-Sajer, I.-A Campean, I.M Lang

Published: 2020-11-26

DOI: 10.1093/ehjci/ehaa946.2255

Source: Full article


Abstract

Abstract